Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Poor Outcome of Patients with COVID-19 after CAR T-Cell Therapy for B-Cell Malignancies: Results from a Multicenter Study on Behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group

Blood (2021) 138 (Supplement 1): 2818.

https://doi.org/10.1182/blood-2021-149466

Published: 2021

Journal Articles

Finding the Best Therapy for Elderly Frail AML Patients: A Retrospective Comparison of 5-Azacytidine and Intensive Approach

Giordana Pastori, MD, Fabio Guolo, MD, Paola Minetto, MD, Marino Clavio, MD, Enrico Balleari, MD, Nicoletta Colombo, Biologist, Giulia Rivoli, MD, Lisette Del Corso, MD, Filippo Ballerini, MD, Livia Giannoni, MD, Laura Mitscheunig, MD, Clara Dellepiane, Daniela Guardo, MD, Maurizio Miglino, PhD, Roberto Massimo Lemoli, MD, Marco Gobbi, MD

Blood (2016) 128 (22): 5202.

https://doi.org/10.1182/blood.V128.22.5202.5202

Published: 2016

Journal Articles

High Prognostic Value of a 3-Genes Molecular Score in Non-High Risk Acute Promyelocytic Leukemia Treated with AIDA 2000 Protocol: A Retrospective Study from a Regional Register

Guardo Daniela, MD, Fabio Guolo, MD, Paola Minetto, MD, Marino Clavio, MD, Livia Giannoni, MD, Elisa Coviello, MD, Giordana Pastori, MD, Giulia Rivoli, MD, Filippo Ballerini, MD, Nicoletta Colombo, PhD, Raffaella Grasso, PhD, Maurizio Miglino, PhD, Roberto Massimo Lemoli, MD, Marco Gobbi, MD

Blood (2015) 126 (23): 2601.

https://doi.org/10.1182/blood.V126.23.2601.2601

Published: 2015

Journal Articles

Fludarabine, Cytarabine, Daunoxome Plus Dasatinib Has High Efficacy with an Acceptable Toxicity Profile As Either Consolidation or Salvage Regimen in Adult Philadelphia Positive Acute Lymphoblastic Leukemia Patients

Giordana Pastori, MD, Fabio Guolo, MD, Daniela Guardo, MD, Paola Minetto, MD, Marino Clavio, MD, Maurizio Miglino, PhD, Livia Giannoni, MD, Elisa Coviello, MD, Filippo Ballerini, MD, Federica Galaverna, MD, Annalisa Kunkl, PhD, Nicoletta Colombo, PhD, Raffaella Grasso, PhD, Roberto Massimo Lemoli, MD, Marco Gobbi, MD

Blood (2015) 126 (23): 4908.

https://doi.org/10.1182/blood.V126.23.4908.4908

Published: 2015

Journal Articles

High Predictive Value of Pre Transplant Minimal Residual Disease Assessment By Combining WT1 Expression and Flow Cytometry in Acute Myeloid Leukemia

Fabio Guolo, MD, Federica Galaverna, MD, Paola Minetto, MD, Livia Giannoni, MD, Chiara Ghiggi, PhD, Marino Clavio, MD, Carmen Di Grazia, MD, Anna Maria Raiola, MD, Nicoletta Colombo, PhD, Raffaella Grasso, PhD, Maurizio Miglino, PhD, Adalberto Ibatici, MD, Roberto Massimo Lemoli, MD, Marco Gobbi, MD, Andrea Bacigalupo, MD

Blood (2015) 126 (23): 2029.

https://doi.org/10.1182/blood.V126.23.2029.2029

Published: 2015

Journal Articles

Fludarabine, cytarabine and Idarubicin (FLAI-5) with or without Gemtuzumab Ozogamicin Is an Effective and Well Tolerated Regimen for Younger AML Patients: Real Life Data from a Single Center Register

Fabio Guolo, MD, Paola Minetto, MD, Giordana Pastori, MD, Livia Giannoni, MD, Nicoletta Colombo, PhD, Raffaella Grasso, PhD, Francesco Trovato, MD, Marcella Bado, MD, Filippo Ballerini, MD, Marino Clavio, MD, Barbara Rebesco, MD, Maurizio Miglino, PhD, Andrea Bacigalupo, MD, Marco Gobbi, MD, Roberto Lemoli, MD

Blood (2014) 124 (21): 2266.

https://doi.org/10.1182/blood.V124.21.2266.2266

Published: 2014

Journal Articles

Prognostic Value of Minimal Residual Disease Assessed By WT1 Expression Level and Flow Cytometry in Acute Myeloid Leukemia Patients Undergoing Allogeneic Marrow Transplantation

Livia Giannoni, MD, Fabio Guolo, MD, Paola Minetto, MD, Federica Galaverna, MD, Chiara Ghiggi, MD, Marino Clavio, MD, Samuele Bagnasco, MD, Carmen Di Grazia, MD, Raffaella Grasso, PhD, Nicoletta Colombo, PhD, Daniele Avenoso, MD, Giordana Pastori, MD, Filippo Ballerini, MD, Annalisa Kunkl, PhD, Maurizio Miglino, PhD, Roberto Lemoli, MD, Marco Gobbi, MD, Andrea Bacigalupo, MD

Blood (2014) 124 (21): 1027.

https://doi.org/10.1182/blood.V124.21.1027.1027

Published: 2014

Journal Articles

Combined Assessment of WT1 and BAALC Expression Levels Improves Risk Stratification in Myelodysplastic Syndromes

Paola Minetto, MD, Fabio Guolo, MD, Marino Clavio, MD, Laura Mitscheunig, Raffaella Grasso, PhD, Nicoletta Colombo, PhD, Enrico De Astis, MD, Daniele Avenoso, MD, Livia Giannoni, MD, Giordana Pastori, MD, Lisette Del Corso, MD, Enrico Balleari, MD, Filippo Ballerini, MD, Roberto Lemoli, MD, Marco Gobbi, MD, Maurizio Miglino, PhD

Blood (2014) 124 (21): 5603.

https://doi.org/10.1182/blood.V124.21.5603.5603

Published: 2014

Journal Articles

Posaconazole for Primary Antifungal Prophylaxis in AML Patients: A Real Life Single Center Experience and a Comparison with the Historical Cohort

Paola Minetto, MD, Fabio Guolo, MD, Malgorzata Mikulska, MD, Giordana Pastori, MD, Livia Giannoni, MD, Elisa Furfaro, Franca Miletich, Valerio Del Bono, MD, Filippo Ballerini, MD, Marino Clavio, MD, Maurizio Miglino, PhD, Roberto Lemoli, MD, Claudio Viscoli, MD, Marco Gobbi, MD

Blood (2014) 124 (21): 5255.

https://doi.org/10.1182/blood.V124.21.5255.5255

Published: 2014

Journal Articles

Minimal Residual Disease After the First Cycle of Chemotherapy in Acute Myeloid Leukemia: A Comparative Study of WT1 RQ-PCR and 4-Color Flow Cytometry.

Carlo Marani, MD, Raffaella Grasso, PhD, Nicoletta Colombo, Marino Clavio, MD, Fabio Guolo, MD, Annalisa Kunkl, Livia Giannoni, MD, Giuseppina Fugazza, PhD, Roberto Bruzzone, Mario Sessarego, MD, A. M. Carella, MD, Marco Gobbi, MD, Maurizio Miglino, PhD

Blood (2012) 120 (21): 2535.

https://doi.org/10.1182/blood.V120.21.2535.2535

Published: 2012

NARROW

Poor Outcome of Patients with COVID-19 after CAR T-Cell Therapy for B-Cell Malignancies: Results from a Multicenter Study on Behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group

Finding the Best Therapy for Elderly Frail AML Patients: A Retrospective Comparison of 5-Azacytidine and Intensive Approach

High Prognostic Value of a 3-Genes Molecular Score in Non-High Risk Acute Promyelocytic Leukemia Treated with AIDA 2000 Protocol: A Retrospective Study from a Regional Register

Fludarabine, Cytarabine, Daunoxome Plus Dasatinib Has High Efficacy with an Acceptable Toxicity Profile As Either Consolidation or Salvage Regimen in Adult Philadelphia Positive Acute Lymphoblastic Leukemia Patients

High Predictive Value of Pre Transplant Minimal Residual Disease Assessment By Combining WT1 Expression and Flow Cytometry in Acute Myeloid Leukemia

Fludarabine, cytarabine and Idarubicin (FLAI-5) with or without Gemtuzumab Ozogamicin Is an Effective and Well Tolerated Regimen for Younger AML Patients: Real Life Data from a Single Center Register

Prognostic Value of Minimal Residual Disease Assessed By WT1 Expression Level and Flow Cytometry in Acute Myeloid Leukemia Patients Undergoing Allogeneic Marrow Transplantation

Combined Assessment of WT1 and BAALC Expression Levels Improves Risk Stratification in Myelodysplastic Syndromes

Posaconazole for Primary Antifungal Prophylaxis in AML Patients: A Real Life Single Center Experience and a Comparison with the Historical Cohort

Minimal Residual Disease After the First Cycle of Chemotherapy in Acute Myeloid Leukemia: A Comparative Study of WT1 RQ-PCR and 4-Color Flow Cytometry.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only